HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabien Despas Selected Research

Protein Kinase Inhibitors

3/2022Pharmacology and pharmacovigilance of protein kinase inhibitors.
1/2019Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.
1/2019Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer.
1/2017Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabien Despas Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 04/2011
6Drug-Related Side Effects and Adverse Reactions
03/2022 - 06/2014
6Heart Failure
01/2022 - 03/2012
5Lymphoma (Lymphomas)
03/2020 - 10/2015
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 03/2019
4Multiple Myeloma
12/2020 - 06/2014
3Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2019 - 06/2014
2Pathologic Complete Response
03/2022 - 10/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2022 - 01/2020
2Thrombosis (Thrombus)
03/2022 - 04/2011
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2021
2Heart Diseases (Heart Disease)
01/2022 - 09/2021
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 06/2021
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 01/2020
2Dental Caries (Decay, Dental)
01/2018 - 12/2017
2Cardiovascular Diseases (Cardiovascular Disease)
04/2015 - 01/2013
1Hyperpigmentation
03/2022
1Acne Vulgaris
03/2022
1Fever (Fevers)
03/2022
1Alopecia (Baldness)
03/2022
1Abdominal Pain (Pain, Abdominal)
03/2022
1Hyperhidrosis
03/2022
1Dermatitis
03/2022
1Inflammation (Inflammations)
03/2022
1Exfoliative Dermatitis (Erythroderma)
03/2022
1Arthritis (Polyarthritis)
03/2022
1Hypoxia (Hypoxemia)
01/2022
1Osteosarcoma (Osteogenic Sarcoma)
01/2022
1Atrial Fibrillation
01/2022
1Hepatitis
01/2022
1Ischemic Stroke
01/2022
1Nervous System Diseases (Neurological Disorders)
09/2021
1Fatigue
09/2021
1Hallucinations (Hallucination)
09/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
06/2021
1Rheumatoid Arthritis
01/2020
1Melanoma (Melanoma, Malignant)
01/2020
1Skin Neoplasms (Skin Cancer)
01/2020
1Residual Neoplasm
01/2020
1Disease Progression
01/2020
1Cataract (Cataracts)
12/2019
1Confusion (Bewilderment)
12/2019
1Blister (Bulla)
12/2019
1Peptic Ulcer (Peptic Ulcers)
06/2019
1Febrile Neutropenia
04/2019
1Pulmonary Arterial Hypertension
01/2019

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
09/2021 - 05/2013
4Protein Kinase InhibitorsIBA
03/2022 - 01/2017
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2022 - 01/2013
3enzalutamideIBA
01/2022 - 01/2021
3abirateroneIBA
01/2022 - 01/2021
3Tyrosine Kinase InhibitorsIBA
01/2022 - 03/2019
2Rituximab (Mabthera)FDA Link
03/2022 - 04/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 04/2015
2Vincristine (Oncovin)FDA LinkGeneric
03/2022 - 04/2015
2Prednisone (Sone)FDA LinkGeneric
03/2022 - 04/2015
2ibrutinibIBA
01/2021 - 01/2020
2Antidepressive Agents (Antidepressants)IBA
10/2020 - 12/2017
2Psychotropic Drugs (Psychoactive Drugs)IBA
10/2020 - 11/2016
2Antipsychotic Agents (Antipsychotics)IBA
10/2020 - 12/2017
2Imatinib Mesylate (Gleevec)FDA Link
10/2016 - 05/2013
2AnthracyclinesIBA
10/2015 - 01/2013
1Lenalidomide (CC 5013)FDA Link
03/2022
1ColchicineFDA LinkGeneric
03/2022
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2022
1sphingosine kinaseIBA
01/2022
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022
1insulin receptor-related receptor (IRR)IBA
01/2022
1ElectrolytesIBA
06/2021
1Immune Checkpoint InhibitorsIBA
06/2021
1Abiraterone AcetateIBA
01/2021
1VaccinesIBA
12/2020
1Hypnotics and Sedatives (Sedatives)IBA
10/2020
1Anti-Anxiety Agents (Anxiolytics)IBA
10/2020
1Biosimilar PharmaceuticalsIBA
03/2020
1IpilimumabIBA
01/2020
1trans-1,2-dihydro-1,2-naphthalenediolIBA
01/2020
1Abatacept (Orencia)FDA Link
01/2020
1Biological ProductsIBA
01/2020
1Core Binding Factors (Core-Binding Factor)IBA
01/2020
1CholesterolIBA
12/2019
1TabletsIBA
12/2019
1LipidsIBA
12/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019
1GlucocorticoidsIBA
06/2019
1Proton Pump InhibitorsIBA
06/2019
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2019
1AnticoagulantsIBA
06/2019
1pegfilgrastim (Neulasta)FDA Link
04/2019
1OX40 ReceptorsIBA
01/2019
1Drug CombinationsIBA
12/2017
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2017
1Opioid Analgesics (Opioids)IBA
12/2017

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2022 - 04/2011
6Therapeutics
03/2022 - 01/2013
1Castration
01/2021
1Medication Errors (Medication Error)
12/2019
1Polypharmacy
06/2019
1Immunotherapy
01/2019